Earnings

Johnson & Johnson JNJ earnings Q2 2021

0


In this photo illustration a Johnson & Johnson logo is seen in front of a medical syringe and a vial with coronavirus vaccine.

Pavlo Gonchar | SOPA Images | LightRocket | Getty Images

Johnson & Johnson said Wednesday it expects to sell $2.5 billion of its Covid-19 vaccine this year, even as concerns mount over the shot’s effectiveness against the delta variant.

In releasing its second-quarter financial results, the company also reported earnings and revenue that beat Wall Street’s expectations.

Here’s how J&J did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:

  • Adjusted EPS: $2.48 per share vs $2.27 expected.
  • Revenue: $23.31 billion vs $22.21…



Source cnbc.com

How to apply for rental assistance before the eviction ban expires

Previous article

Fed’s Mary Daly says tapering of bond purchases may start this year

Next article

You may also like

Leave a Reply

avatar
  Subscribe  
Notify of

More in Earnings